Table 1 Patient characteristics
Total (n = 595) | No STAAKI (n = 540) | STAAKI (n = 55) | P | |
|---|---|---|---|---|
Age, years | 63.17 ± 13.18 | 63.06 ± 13.39 | 64.25 ± 10.98 | 0.453 |
Female, n (%) | 143 (24.03) | 126 (23.33) | 17 (30.91) | 0.210 |
Heart rate, bpm | 79.92 ± 14.50 | 79.82 ± 14.61 | 80.93 ± 13.49 | 0.589 |
SBP, mmHg | 127.71 ± 20.13 | 127.71 ± 20.26 | 127.76 ± 18.97 | 0.984 |
DBP, mmHg | 79.11 ± 14.00 | 79.08 ± 14.10 | 79.40 ± 13.13 | 0.870 |
BMI, kg/m2 | 24.58 ± 3.85 | 24.51 ± 3.88 | 25.27 ± 3.49 | 0.164 |
Smoking, n (%) | 276 (46.39) | 256 (47.41) | 20 (36.36) | 0.118 |
Hypertension, n (%) | 264 (44.37) | 239 (44.26) | 25 (45.45) | 0.865 |
Diabetes, n (%) | 157 (26.39) | 136 (25.19) | 21 (38.18) | 0.037 |
CKD, n (%) | 21 (3.53) | 20 (3.70) | 1 (1.82) | 0.735 |
HGB, g/L | 139.82 ± 17.02 | 139.92 ± 17.02 | 138.84 ± 17.12 | 0.654 |
Plt, 10^9/L | 216.62 ± 58.71 | 217.39 ± 59.62 | 209.09 ± 48.67 | 0.318 |
Creatinine, µmol/L | 67.24 ± 20.32 | 67.50 ± 20.61 | 64.67 ± 17.25 | 0.326 |
eGFR, mL/min/1.73 m2 | 102.38 ± 20.63 | 102.56 ± 20.81 | 100.65 ± 18.84 | 0.512 |
Total cholesterol, mmol/L | 4.26 ± 1.01 | 4.25 ± 1.02 | 4.38 ± 0.94 | 0.388 |
Triglycerides, mmol/L | 1.51 ± 1.13 | 1.52 ± 1.17 | 1.45 ± 0.72 | 0.685 |
HDL-C, mmol/L | 0.98 ± 0.24 | 0.98 ± 0.24 | 1.00 ± 0.16 | 0.516 |
LDL-C, mmol/L | 2.74 ± 0.87 | 2.72 ± 0.88 | 2.90 ± 0.85 | 0.166 |
ABG, mmol/L | 7.86 ± 3.17 | 7.67 ± 2.93 | 9.68 ± 4.63 | 0.003 |
HBA1c, % | 6.55 ± 1.71 | 6.56 ± 1.74 | 6.40 ± 1.29 | 0.488 |
ADAG, mmol/L | 7.82 ± 2.71 | 7.85 ± 2.77 | 7.58 ± 2.05 | 0.488 |
GG, mmol/L | 0.04 ± 2.42 | -0.17 ± 2.24 | 2.10 ± 3.09 | < 0.001 |
Peak hs-CRP, mg/L | 2.20 (0.50, 7.65) | 2.10 (0.50, 7.35) | 2.70 (1.50, 9.35) | 0.026 |
Peak hs-TnT, ng/L | 528.0 (96.8, 1907.5) | 492.8 (82.3, 1972.5) | 1041.0 (157.0, 1616.0) | 0.104 |
Peak NT-proBNP, pg/mL | 1344.0 (564.6, 3033.6) | 1200.0 (507.8, 2749.8) | 3000.00 (1706.5, 4387.0) | < 0.001 |
IABP, n (%) | 16 (2.69) | 14 (2.59) | 2 (3.64) | 0.985 |
LVEF, % | 51.89 ± 6.99 | 52.32 ± 6.78 | 47.73 ± 7.75 | < 0.001 |
Killip class, n (%) | 0.137 | |||
I | 511 (85.88) | 468 (86.67) | 43 (78.18) | |
II | 28 (4.71) | 26 (4.81) | 2 (3.64) | |
III | 1 (0.17) | 1 (0.19) | 0 (0.00) | |
IV | 55 (9.24) | 45 (8.33) | 10 (18.18) | |
IRA-LAD, n(%) | 296 (49.75) | 261 (48.33) | 35 (63.64) | 0.031 |
IRA-LCX n(%) | 58 (9.75) | 53 (9.81) | 5 (9.09) | 0.863 |
IRA-RCA, n(%) | 238 (40.00) | 223 (41.30) | 15 (27.27) | 0.043 |
IRA-Left main, n(%) | 3 (0.50) | 3 (0.56) | 0 (0.00) | 1.000 |
Aspirin, n(%) | 593 (99.66) | 538 (99.63) | 55 (100.00) | 1.000 |
P2Y12, n(%) | 594 (99.83) | 539 (99.81) | 55 (100.00) | 1.000 |
Statins, n(%) | 592 (99.50) | 537 (99.44) | 55 (100.00) | 1.000 |
ACEI/ARB, n(%) | 272 (45.71) | 246 (45.56) | 26 (47.27) | 0.808 |
β-blockers, n(%) | 516 (86.72) | 469 (86.85) | 47 (85.45) | 0.771 |
Nitrates, n(%) | 237 (39.83) | 220 (40.74) | 17 (30.91) | 0.156 |
Heparin, n(%) | 493 (82.86) | 448 (82.96) | 45 (81.82) | 0.830 |
Diuretics, n(%) | 298 (50.08) | 263 (48.70) | 35 (63.64) | 0.035 |